| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.00085 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |